Hap Trading, LLC Inovio Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $846 - $1,500	600 Added 1.12%	54,200 $1,000
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $13,446 - $22,599	8,100 Added 17.8%	53,600 $6,000
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.98 $10,080 - $27,860	7,000 Added 18.18%	45,500 $4,000
Q1 2022 May 12, 2022	SELL	$2.97 - $5.2 $182,952 - $320,320	-61,600 Reduced 61.54%	38,500 $7,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $97,804 - $146,216	19,600 Added 24.35%	100,100 $29,000
Q3 2021 Nov 10, 2021	SELL	$7.16 - $9.69 $96,660 - $130,815	-13,500 Reduced 14.36%	80,500 $16,000
Q2 2021 Aug 11, 2021	BUY	$6.23 - $10.03 $42,987 - $69,207	6,900 Added 7.92%	94,000 $121,000
Q1 2021 May 14, 2021	SELL	$8.81 - $16.96 $81,052 - $156,032	-9,200 Reduced 9.55%	87,100 $104,000
Q4 2020 Feb 16, 2021	SELL	$8.5 - $12.85 $475,150 - $718,315	-55,900 Reduced 36.73%	96,300 $68,000
Q3 2020 Nov 13, 2020	BUY	$9.57 - $27.05 $482,328 - $1.36 Million	50,400 Added 49.51%	152,200 $141,000
Q2 2020 Aug 10, 2020	BUY	$7.14 - $31.69 $229,908 - $1.02 Million	32,200 Added 46.26%	101,800 $1.08 Million
Q1 2020 May 08, 2020	BUY	$2.98 - $14.09 $207,408 - $980,664	69,600 New	69,600 $98,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.